Bellinato, Francesco
Gisondi, Paolo
Filippucci, Emilio
Tozzi, Francesca
Fassio, Angelo
Adami, Giovanni
Idolazzi, Luca
Funding for this research was provided by:
Università degli Studi di Verona
Article History
Received: 25 May 2022
Revised: 27 September 2022
Accepted: 11 October 2022
First Online: 21 October 2022
Change Date: 25 November 2022
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1007/s00403-022-02474-5
Declarations
:
: Giovanni Adami declares personal fees from Theramex, Francesco Bellinato, Emilio Filippucci, Francesca Tozzi and Angelo Fassio declare that they have no conflict of interest related to the present paper. Luca Idolazzi served as consultant and/or speaker for AbbVie, Amgen, Biogen, Merck, Sharp & Dohme, Eli-Lilly, Novartis, Celgene, Sandoz. Paolo Gisondi served as a speaker for Abbvie, Almirall, Amgen, Biogen, Eli Lilly, Jansenn, Novartis, Sanofi, UCB.